QuickLinks -- Click here to rapidly navigate through this document



U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549


FORM 40-F


(Check one)

 
o REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934

OR

ý

ANNUAL REPORT PURSUANT TO SECTION 13(a) OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the fiscal year ended December 31, 2005 Commission File Number 0-30752

ÆTERNA ZENTARIS INC.
(Exact name of registrant as specified in its charter)

CANADA   2834   Not Applicable
(Province or other jurisdiction of
incorporation or organization)
  (Primary Standard Industrial
Classification Code Number)
  (I.R.S. Employer Identification Number)

1405, boul. du Parc-Technologique
Québec, Québec
Canada, G1P 4P5
(418) 652-8525

 

CT Corporation System
111 Eighth Avenue
13th Floor
New York, NY 10011
(212) 894-8638
(Address and telephone number of
Registrant's principal executive offices)
  (Name, address and telephone number of agent
for service of process in the United States)

Securities registered or to be registered pursuant to Section 12(b) of the Act:

Title of each class

 

Name of each exchange on which registered

Not Applicable   Not Applicable

Securities registered or to be registered pursuant to Section 12(g) of the Act:

 

 

Common Shares


 

 
    (Title of Class)    

Securities for which there is a reporting obligation pursuant to Section 15(d) of the Act.

 

 

Not Applicable


 

 
    (Title of Class)    

For annual reports, indicate by check mark the information filed with this Form:

ý    Annual information form

 

 

 

ý    Audited annual financial statements

Indicate the number of outstanding shares of each of the issuer's classes of capital or common stock as of the close of the period covered by the annual report.

53,133,681 Common Shares Outstanding
0 First Preferred Shares
0 Second Preferred Shares

Indicate by check mark whether the Registrant by filing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934 (the "Exchange Act"). If "Yes" is marked, indicate the filing number assigned to the Registrant in connection with such Rule.

Yes o            No ý

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.

Yes ý            No o





ÆTERNA ZENTARIS INC.

ANNUAL REPORT ON FORM 40-F


Controls and Procedures

        The Registrant's President and Chief Executive Officer and the Registrant's Vice President and Chief Financial Officer have concluded, based on their evaluation of the effectiveness of the Registrant's disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended), that the Registrant's disclosure controls and procedures are effective as of the end of the period covered by this annual report on Form 40-F.

        There has been no change in the Registrant's internal control over financial reporting that occurred during the period covered by this annual report on Form 40-F that has materially affected, or is reasonably likely to materially affect, the Registrant's internal control over financial reporting.


Corporate Governance

        The Registrant is in compliance with the corporate governance requirements of The Nasdaq Stock Market, Inc. ("NASDAQ") except for the requirement that a quorum for a meeting of the holders of the common stock of the Registrant be no less than 331/3% of such outstanding shares. The by-laws of the Registrant provide that a quorum for purposes of any meeting of shareholders of the Registrant consists of at least 20% of the outstanding voting shares. The Registrant received an exemption from NASDAQ from this quorum requirement because the quorum provided for in the by-laws of the Registrant is consistent with generally accepted business practices in Canada, the Registrant's country of domicile, and with the Toronto Stock Exchange, the principal market on which the Registrant's voting shares are traded.


Code of Ethical Conduct

        On March 29, 2004, the Board of Directors adopted a "Code of Ethical Conduct", which was amended by the Board of Directors on November 3, 2004 and on December 13, 2005. The December 13, 2005 amendment incorporates changes to the duty to report violations consistent with applicable laws. The Registrant has selected an independent third party supplier to provide a confidential and anonymous communication channel for reporting concerns about possible violations to the Registrant's Code of Ethical Conduct as well as financial and/or accounting irregularities or fraud. A copy of the Code of Ethical Conduct, as amended, is attached as Exhibit 8 to this annual report on Form 40-F and is also available on the Registrant's Web site at www.aeternazentaris.com in Investors/Governance. The Code of Ethical Conduct is a "code of ethics" as defined in paragraph (9)(b) of General Instruction B to Form 40-F. The Code of Ethical Conduct applies to all of the Registrant's employees, directors and officers, including the Registrant's principal executive officer, principal financial officer, and principal accounting officer or controller, or persons performing similar functions, and includes specific provisions dealing with integrity in accounting matters, conflicts of interest and compliance with applicable laws and regulations. The Registrant will provide this document to any person or company upon request to the Corporate Secretary of the Registrant, at its head office at 1405 du Parc-Technologique Boulevard, Quebec City, Quebec, G1P 4P5, Canada.



Audit Committee Financial Expert

        The Board of Directors of the Registrant has determined that the Registrant has at least one audit committee financial expert (as defined in paragraph 8(b) of General Instruction B to Form 40-F). The name of the audit committee financial expert of the Registrant is Mr. Gérard Limoges, the Audit Committee's Chairman. The Commission has indicated that the designation of Mr. Limoges as the audit committee financial expert of the Registrant does not (i) make Mr. Limoges an "expert" for any purpose, including without limitation for purposes of Section 11 of the Securities Act of 1933, as amended, as a result of this designation; (ii) impose any duties, obligations or liability on Mr. Limoges that are greater than those imposed on him as a member of the Audit Committee and the Board of Directors in the absence of such designation; or (iii) affect the duties, obligations or liability of any other member of the Audit Committee or the Board of Directors.


Audit Committee, External Auditor's Fees and Pre-Approval Policies and Procedures

        The Registrant has a separately designated standing Audit Committee established in accordance with Section 3(a)(58)(A) of the Exchange Act. The Board of Directors is of the view that each of the members of the Audit Committee is "independent" as defined by the Marketplace Rules of NASDAQ.

        Information regarding the composition of the Registrant's Audit Committee, the fees billed by the Registrant's external auditor for each of the years ended December 31, 2004 and 2005 and the pre-approval policies and procedures adopted by the Audit Committee is incorporated into this annual report on Form 40-F by reference from the Registrant's Management Proxy Circular dated March 15, 2006, which is filed as Exhibit 6 to this annual report on Form 40-F.

        For each of the years ended December 31, 2004 and 2005, none of the non-audit services provided by the Registrant's external auditor were approved by the Audit Committee pursuant to the "de minimis exception" to the pre-approval requirement for non-audit services.


Off-Balance Sheet Arrangements

        There is no off-balance sheet arrangement as at December 31, 2005.


Documents Filed Pursuant to General Instructions

        In accordance with General Instruction D.(9) of Form 40-F, the Registrant hereby files Exhibit 7 as set forth in the Exhibit Index attached hereto.

2



Undertaking and Consent to Service of Process

A.    Undertaking

        The Registrant undertakes to make available, in person or by telephone, representatives to respond to inquiries made by the Commission staff, and to furnish promptly, when requested to do so by the Commission staff, information relating to: the securities registered pursuant to Form 40-F; the securities in relation to which the obligation to file an annual report on Form 40-F arises; or transactions in said securities.

B.    Consent to Service of Process

        The Registrant has previously filed with the Commission a written consent to service of process and power of attorney on Form F-X.

3



Signatures

        Pursuant to the requirements of the Exchange Act, the Registrant certifies that it meets all of the requirements for filing on Form 40-F and has duly caused this Annual Report to be signed on its behalf by the undersigned, thereto duly authorized.

    ÆTERNA ZENTARIS INC.

Date: March 31, 2006

 

By:

 

GRAPHIC
        Name:   Mario Paradis
        Title:   Senior Finance Director and Corporate Secretary


EXHIBIT INDEX

Exhibit Number
  Document
1   Annual Information Form of Registrant, dated March 24, 2006, for the year ended December 31, 2005

2

 

Report of Independent Auditors

3

 

Audited Consolidated Balance Sheets of Registrant, including the Notes thereto, as at December 31, 2005 and 2004 and Audited Consolidated Statements of Deficit, Consolidated Statements of Contributed Surplus, Consolidated Statements of Operations and Consolidated Statements of Cash Flows for the years ended December 31, 2005, 2004 and 2003

4

 

Annual Report of the Registrant for the year ended December 31, 2005

5

 

Management's Discussion and Analysis of Financial Condition and Results of Operations for the financial year ended December 31, 2005

6

 

Registrant's Management Proxy Circular dated March 15, 2006

7

 

Consent of Independent Accountants

8

 

Code of Ethical Conduct, as amended on December 13, 2005

31.1

 

Certification of the Chief Executive Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002

31.2

 

Certification of the Chief Financial Officer pursuant to Section 302 of Sarbanes-Oxley Act of 2002

32.1

 

Certification of the Chief Executive Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002

32.2

 

Certification of the Chief Financial Officer pursuant to Section 906 of Sarbanes-Oxley Act of 2002



QuickLinks

ÆTERNA ZENTARIS INC. ANNUAL REPORT ON FORM 40-F
Controls and Procedures
Corporate Governance
Code of Ethical Conduct
Audit Committee Financial Expert
Audit Committee, External Auditor's Fees and Pre-Approval Policies and Procedures
Off-Balance Sheet Arrangements
Documents Filed Pursuant to General Instructions
Undertaking and Consent to Service of Process
Signatures
EXHIBIT INDEX